Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium [Phase 1, Phase 2]
A Phase 1/2 trial investigating gemcitabine hydrochloride, cisplatin, and temsirolimus as first-line therapy for locally advanced or metasta…
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence [Phase 2]
Phase 2 clinical trial assessing the effectiveness and safety of intravesical docetaxel instillation to prevent bladder recurrence in urothe…
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 trial of apaziquone versus placebo in non-muscle invasive bladder cancer was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors [NA]
Clinical trial NCT01567462 evaluating PlasmaKinetic PK Button Vaporization Electrode for bladder tumor treatment has completed and posted re…
-
CLINICAL_TRIALS research · 2017-11-20Clinical Trial Update: Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care [NA]
A clinical trial update about a trimodal prehabilitation approach for cystectomy patients aimed at improving post-operative care; current st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with or without OGX-427 in relapsed/refractory metastatic bladder cancer; study completed with posted res…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia [NA]
Completed clinical trial evaluating respiratory monitoring with an infrared camera and the ExSpiron 1Xi during sedation for TURP/TURB under …
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures
An update on a clinical trial evaluating the Uro-C cystoscope for diagnostic cystoscopy in patients with bladder cancer; the current status …
-
FDA approval · 2017-11-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for doxorubicin hydrochloride from BluePoint Laboratories, adding a new approved generic version of …
-
CLINICAL_TRIALS research · 2017-11-01Clinical Trial Update: Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors [NA]
Clinical trial update for an outpatient, PDD-guided laser procedure aimed at destroying bladder tumors; the entry lists bladder cancer as th…
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating a combination of sirolimus, cisplatin, and gemcitabine hydrochl…
-
CLINICAL_TRIALS research · 2017-10-19Clinical Trial Update: TURBt With Adjuvant Cryoablation to Treat Bladder Cancer [NA]
It provides an update on a clinical trial evaluating transurethral resection of bladder tumor (TURBt) with adjuvant cryoablation for bladder…
-
CLINICAL_TRIALS withdrawal · 2017-10-19Clinical Trial Update: Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer [Phase 2]
A Phase 2 trial evaluating radiation therapy with durvalumab, with or without tremelimumab, for bladder cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2017-10-17Clinical Trial Update: Prospective Clinical Trial - Obturator Reflex Predictors and Blockage [NA]
A prospective clinical trial conducted at Rabin Medical Center evaluating obturator reflex predictors and blockage in bladder cancer patient…
-
CLINICAL_TRIALS research · 2017-10-11Clinical Trial Update: Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development [NA]
This document reports an update on a clinical trial evaluating a PET/MRI tracer to better understand prostate cancer development. The study …
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
A completed clinical trial evaluates the severity of overactive bladder symptoms in patients after Synergo treatment for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy [Phase 2]
Phase 2 clinical trial evaluating a preoperative high-arginine nutritional supplement before radical cystectomy for bladder cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Chemoradiotherapy for Recurrent T1G3 Bladder Cancer [Phase 4]
Phase 4 clinical trial update evaluating chemoradiotherapy for recurrent T1G3 bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
A completed clinical trial update reports that the NMP22 biomarker test shows improved sensitivity for detecting bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. [Phase 4]
A Phase 4 trial assessing whether TachoSil reduces lymphoceles after extended pelvic lymph node dissection in prostate or bladder cancer; th…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy [Phase 2]
A Phase 2 trial evaluating gemcitabine plus pazopanib for chemotherapy-naïve, advanced/metastatic urothelial carcinoma ineligible for cispla…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) [Phase 3]
Phase 3 clinical trial update for single-dose intravesical apaziquone after TURBT in noninvasive bladder cancer patients; study completed wi…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization [NA]
An exploratory study evaluating advanced PET/MRI metrics for bladder cancer characterization; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: An Educational Intervention for Patients With Bladder Cancer [NA]
The clinical trial evaluating an educational intervention for patients with bladder cancer has completed.